Related references
Note: Only part of the references are listed.The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment
H. Jethwa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
B. S. Fernandes et al.
MOLECULAR PSYCHIATRY (2016)
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases
George E. Fragoulis et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Common susceptibility variants are shared between schizophrenia and psoriasis in the Han Chinese population
Xianyong Yin et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2016)
Risk of Psychiatric Disorders following Ankylosing Spondylitis: A Nationwide Population-based Retrospective Cohort Study
Cheng-Che Shen et al.
JOURNAL OF RHEUMATOLOGY (2016)
Schizophrenia risk from complex variation of complement component 4
Aswin Sekar et al.
NATURE (2016)
T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model
Anastasiya Slyepchenko et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Bias in Peripheral Depression Biomarkers
Andre F. Carvalho et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2016)
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
Gloria B. Choi et al.
SCIENCE (2016)
The role of IL-17 in CNS diseases
Ari Waisman et al.
ACTA NEUROPATHOLOGICA (2015)
Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells
Koji Atarashi et al.
CELL (2015)
Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis
Philip J. Mease
CURRENT OPINION IN RHEUMATOLOGY (2015)
Increased interleukin 23 (IL23) levels in schizophrenia patients treated with depot antipsychotic medication
Kara E. O'Connell et al.
CYTOKINE (2015)
Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment
Monojit Debnath
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Cytokine profile in drug-naive, first episode patients with psychosis
Petros Petrikis et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
The IL-23-IL-17 axis in inflammatory arthritis (vol 11, pg 415, 2015)
Erik Lubberts
NATURE REVIEWS RHEUMATOLOGY (2015)
C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients
Mohamed Jalloul Nsaiba et al.
NEUROCHEMICAL RESEARCH (2015)
Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia
B. Pyndt Jorgensen et al.
PHYSIOLOGY & BEHAVIOR (2015)
Schizophrenia and the gut-brain axis
Katlyn Nemani et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2015)
Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia
Yousri El Kissi et al.
PSYCHIATRY RESEARCH (2015)
Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia
Milica Borovcanin et al.
PSYCHONEUROENDOCRINOLOGY (2015)
Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls
Sigrun Hope et al.
SCHIZOPHRENIA RESEARCH (2015)
High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
Cristiano Noto et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2015)
Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease
Cristina-Sorina Catana et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration
Daniel May de Oliveira et al.
INFLAMMOPHARMACOLOGY (2015)
Dietary Omega-3 Fatty Acids Suppress Experimental Autoimmune Uveitis in Association with Inhibition of Th1 and Th17 Cell Function
Hiromi Shoda et al.
PLOS ONE (2015)
Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries
Justin Davis et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)
Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions
Dieter Schoepf et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2014)
Atopic disorders and depression: Findings from a large, population-based study
Livia Sanna et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Therapeutic potential of atorvastatin-modified dendritic cells in experimental autoimmune neuritis by decreased-Thl/Th17 cytokines and up-regulated T regulatory cells and NKR-P1+ cells
Hua Xu et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Genomics of schizophrenia: time to consider the gut microbiome?
T. G. Dinan et al.
MOLECULAR PSYCHIATRY (2014)
Activation of Th17 cells in drug naive, first episode schizophrenia
Minli Ding et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Lovastatin for the adjunctive treatment of schizophrenia: A preliminary randomized double-blind placebo-controlled trial
Ahmad Ghanizadeh et al.
PSYCHIATRY RESEARCH (2014)
Th17 Pathway-Mediated Immunopathogenesis of Schizophrenia: Mechanisms and Implications
Monojit Debnath et al.
SCHIZOPHRENIA BULLETIN (2014)
Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine
Kara E. O'Connell et al.
SCHIZOPHRENIA RESEARCH (2014)
Genetic liability for schizophrenia predicts risk of immune disorders
Sven Stringer et al.
SCHIZOPHRENIA RESEARCH (2014)
A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence
Golam M. Khandaker et al.
SCHIZOPHRENIA RESEARCH (2014)
Interleukin-17 inhibits Adult Hippocampal Neurogenesis
Qiang Liu et al.
SCIENTIFIC REPORTS (2014)
Poststroke Neuropsychiatric Symptoms: Relationships with IL-17 and Oxidative Stress
W. Swardfager et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Sarah L. Gaffen et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Add-on clinical effects of simvastatin and ondansetron in patients with schizophrenia stabilized on antipsychotic treatment: pilot study
Imran B. Chaudhry et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)
Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects
Brian J. Miller et al.
BIOLOGICAL PSYCHIATRY (2013)
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
Mehdi Farokhnia et al.
CLINICAL NEUROPHARMACOLOGY (2013)
IL-23/IL-17A Axis Correlates with the Nitric Oxide Pathway in Inflammatory Bowel Disease: Immunomodulatory Effect of Retinoic Acid
Hayet Rafa et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)
Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
S. G. Fillman et al.
MOLECULAR PSYCHIATRY (2013)
Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival
R. Todd Stravitz et al.
LIVER INTERNATIONAL (2013)
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
S. Hong Lee et al.
NATURE GENETICS (2013)
Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia
George Anderson et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: Potential role for IL-17 pathway
Dimitre H. Dimitrov et al.
SCHIZOPHRENIA RESEARCH (2013)
Antipsychotics can modulate the cytokine profile in schizophrenia: Attenuation of the type-2 inflammatory response
Milica Borovcanin et al.
SCHIZOPHRENIA RESEARCH (2013)
Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia
Emily G. Severance et al.
SCHIZOPHRENIA RESEARCH (2013)
Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study
Shaw-Ji Chen et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway
Kyung-Ah Cho et al.
INTERNATIONAL IMMUNOLOGY (2012)
Increased IgA and IgM responses against gut commensals in chronic depression: Further evidence for increased bacterial translocation or leaky gut
Michael Maes et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse
Milica Borovcanin et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Increased serum levels of C3 and C4 in patients with schizophrenia compared to eutymic patients with bipolar disorder and healthy
Lisiane dos Santos Sória et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2012)
Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome
Wouter Beumer et al.
PSYCHONEUROENDOCRINOLOGY (2012)
Interleukin-23: A key cytokine in inflammatory diseases
Emilie Duvallet et al.
ANNALS OF MEDICINE (2011)
Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls
Marcella Reale et al.
BMC NEUROSCIENCE (2011)
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Yun Kyung Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Normal gut microbiota modulates brain development and behavior
Rochellys Diaz Heijtza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
IL-17A stimulates the expression of inflammatory cytokines via celecoxib-blocked prostaglandin in MC3T3-E1 cells
Fan Zhang et al.
ARCHIVES OF ORAL BIOLOGY (2010)
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Jula Huppert et al.
FASEB JOURNAL (2010)
IL-23/IL-17 Axis in IBD
Massimiliano Sarra et al.
INFLAMMATORY BOWEL DISEASES (2010)
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Kamran Ghoreschi et al.
NATURE (2010)
Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma
Stephane Lajoie et al.
NATURE IMMUNOLOGY (2010)
Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
Norbert Mueller et al.
SCHIZOPHRENIA RESEARCH (2010)
Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production
Chongyun Fang et al.
BLOOD (2009)
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivaylo I. Ivanov et al.
CELL (2009)
Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder
Marcia Kauer-Sant'Anna et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis
Jayasri Das Sarma et al.
JOURNAL OF NEUROINFLAMMATION (2009)
N-acetyl cysteine as a glutathione precursor for schizophrenia - A double-blind, randomized, placebo-controlled trial
Michael Berk et al.
BIOLOGICAL PSYCHIATRY (2008)
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs
Xuexian O. Yang et al.
IMMUNITY (2008)
IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
Gretta L. Stritesky et al.
JOURNAL OF IMMUNOLOGY (2008)
The Interleukin-23/Interleukin-17 axis in intestinal inflammation
Kevin J. Maloy
JOURNAL OF INTERNAL MEDICINE (2008)
Production and functions of IL-17 in microglia
Jun Kawanokuchi et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology
Mandy J. McGeachy et al.
NATURE IMMUNOLOGY (2007)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
TH-17 cells in the circle of immunity and autoimmunity
Estelle Bettelli et al.
NATURE IMMUNOLOGY (2007)
Monocytic, Th1 and Th2 cytokine alterations in the pathophysiology of schizophrenia
Kyeong-Sae Na et al.
NEUROPSYCHOBIOLOGY (2007)
Interleukin-23 drives innate and T cell-mediated intestinal inflammation
Sophie Hue et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
Y Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Th1, Th2 and Th3 cytokine alteration in schizophrenia
YK Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
Clinical potential of omega-3 fatty acids in the treatment of schizophrenia
R Emsley et al.
CNS DRUGS (2003)
Share Paper
